A detailed history of Sonora Investment Management Group, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Sonora Investment Management Group, LLC holds 150,814 shares of IONS stock, worth $6.81 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
150,814
Previous 149,338 0.99%
Holding current value
$6.81 Million
Previous $7.56 Million 13.47%
% of portfolio
0.6%
Previous 0.77%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$42.03 - $53.55 $62,036 - $79,039
1,476 Added 0.99%
150,814 $6.54 Million
Q4 2023

Feb 14, 2024

BUY
$43.39 - $51.63 $38,530 - $45,847
888 Added 0.6%
149,338 $7.56 Million
Q3 2023

Nov 02, 2023

SELL
$38.5 - $47.13 $67,567 - $82,713
-1,755 Reduced 1.17%
148,450 $6.73 Million
Q2 2023

Aug 10, 2023

SELL
$34.73 - $43.33 $91,270 - $113,871
-2,628 Reduced 1.72%
150,205 $6.16 Million
Q1 2023

May 12, 2023

SELL
$33.58 - $41.2 $110,209 - $135,218
-3,282 Reduced 2.1%
152,833 $5.46 Million
Q4 2022

Feb 13, 2023

SELL
$37.12 - $46.52 $33,704 - $42,240
-908 Reduced 0.58%
156,115 $5.9 Million
Q3 2022

Nov 03, 2022

BUY
$36.54 - $48.66 $25,578 - $34,062
700 Added 0.45%
157,023 $5.81 Million
Q2 2022

Aug 15, 2022

SELL
$31.71 - $43.0 $29,743 - $40,334
-938 Reduced 0.6%
156,323 $5.79 Million
Q1 2022

May 12, 2022

BUY
$29.88 - $37.04 $14,073 - $17,445
471 Added 0.3%
157,261 $5.83 Million
Q4 2021

Feb 11, 2022

BUY
$25.61 - $35.1 $4.02 Million - $5.5 Million
156,790 New
156,790 $4.77 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $6.41B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Sonora Investment Management Group, LLC Portfolio

Follow Sonora Investment Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sonora Investment Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sonora Investment Management Group, LLC with notifications on news.